Functional neuronal network activity differs with cognitive dysfunction in childhood-onset systemic lupus erythematosus

被引:26
|
作者
DiFrancesco, Mark W. [1 ]
Gitelman, Darren R. [2 ,3 ]
Klein-Gitelman, Marisa S. [4 ]
Sagcal-Gironella, Anna Carmela P. [5 ]
Zelko, Frank [6 ]
Beebe, Dean [7 ]
Parrish, Todd [3 ]
Hummel, Jessica [5 ]
Ying, Jun [8 ]
Brunner, Hermine I. [5 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA
[3] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA
[4] Northwestern Univ, Feinberg Sch Med, Ann & Robert Lurie Childrens Hosp, Div Rheumatol, Chicago, IL 60611 USA
[5] Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH 45229 USA
[6] Northwestern Univ, Feinberg Sch Med, Ann & Robert Lurie Childrens Hosp, Dept Child & Adolescent Psychiat, Chicago, IL 60611 USA
[7] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Child Psychol, Cincinnati, OH 45229 USA
[8] Univ Cincinnati, Dept Publ Hlth, Cincinnati, OH 45221 USA
关键词
NEUROPSYCHIATRIC MANIFESTATIONS; WILLIAMS-SYNDROME; DISEASE-ACTIVITY; K-ABC; PREVALENCE; IMPAIRMENT; FMRI; MRI; ACTIVATION; PATTERNS;
D O I
10.1186/ar4197
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Neuropsychiatric manifestations are common in childhood-onset systemic lupus erythematosus (cSLE) and often include neurocognitive dysfunction (NCD). Functional magnetic resonance imaging (fMRI) can measure brain activation during tasks that invoke domains of cognitive function impaired by cSLE. This study investigates specific changes in brain function attributable to NCD in cSLE that have potential to serve as imaging biomarkers. Methods: Formal neuropsychological testing was done to measure cognitive ability and to identify NCD. Participants performed fMRI tasks probing three cognitive domains impacted by cSLE: visuoconstructional ability (VCA), working memory, and attention. Imaging data, collected on 3-Tesla scanners, included a high-resolution T1-weighted anatomic reference image followed by a T2*-weighted whole-brain echo planar image series for each fMRI task. Brain activation using blood oxygenation level-dependent contrast was compared between cSLE patients with NCD (NCD-group, n = 7) vs. without NCD (noNCD-group, n = 14) using voxel-wise and region of interest-based analyses. The relationship of brain activation during fMRI tasks and performance in formal neuropsychological testing was assessed. Results: Greater brain activation was observed in the noNCD-group vs. NCD-group during VCA and working memory fMRI tasks. Conversely, compared to the noNCD-group, the NCD-group showed more brain activation during the attention fMRI task. In region of interest analysis, brain activity during VCA and working memory fMRI tasks was positively associated with the participants' neuropsychological test performance. In contrast, brain activation during the attention fMRI task was negatively correlated with neuropsychological test performance. While the NCD group performed worse than the noNCD group during VCA and working memory tasks, the attention task was performed equally well by both groups. Conclusions: NCD in patients with cSLE is characterized by differential activation of functional neuronal networks during fMRI tasks probing working memory, VCA, and attention. Results suggest a compensatory mechanism allows maintenance of attentional performance under NCD. This mechanism appears to break down for the VCA and working memory challenges presented in this study. The observation that neuronal network activation is related to the formal neuropsychological testing performance makes fMRI a candidate imaging biomarker for cSLE-associated NCD.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Potential Biomarkers of Cognitive Impairment in the Context of Childhood-onset Systemic Lupus Erythematosus
    Arciniegas, Santiago
    Mossad, Sarah
    El Tal, Tala
    Ng, Lawrence
    Moaf, Paris
    Branson, Helen
    Davis, Adrienne
    Hiraki, Linda
    Levy, Deborah
    Danguecan, Ashley
    Ibrahim, George
    Knight, Andrea
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 817 - 817
  • [22] Potential Biomarkers of Cognitive Impairment in the Context of Childhood-Onset Systemic Lupus Erythematosus
    Arciniegas, Santiago
    Mossad, Sarah
    El Tal, Tala
    Ng, Lawrence
    Moaf, Paris
    Branson, Helen
    Davis, Adrienne
    Hiraki, Linda
    Levy, Deborah
    Danguecan, Ashley
    Knight, Andrea
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1586 - 1588
  • [23] TNF-α Is Associated With Cognitive Impairment In Childhood-Onset Systemic Lupus Erythematosus
    Postal, Mariana
    Sinicato, Nailu A.
    Lapa, Aline T.
    Pelicari, Karina
    Bellini, Bruna
    Fernandes, Paula T.
    Marini, Roberto
    Appenzeller, Simone
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S938 - S939
  • [24] Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus
    Colin Thorbinson
    Louise Oni
    Eve Smith
    Angela Midgley
    Michael W. Beresford
    Pediatric Drugs, 2016, 18 : 181 - 195
  • [25] Childhood-Onset Systemic Lupus Erythematosus: A Cohort Study
    Ahmed, Shakeel
    Ali, Syed Rehan
    Karim, Farida
    Ishaq, Sidra
    Qaiser, Iman
    Nayani, Kanwal
    Ahmed, Ayesha
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2018, 28 (05): : 365 - 369
  • [26] Pharmacokinetics of Hydroxychloroquine in childhood-onset systemic lupus erythematosus
    Zahr, N.
    Gillion-Boyer, O.
    Bader-Meunier, B.
    Melki, I.
    Urien, U.
    Funck-Brentano, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 42 - 43
  • [27] Rituximab therapy for childhood-onset systemic lupus erythematosus
    Haddad, E
    Willems, M
    Niaudet, P
    Koné-Paut, I
    Bensman, A
    Cochat, P
    Deschênes, G
    Fakhouri, F
    Leblanc, T
    Llanas, B
    Loirat, C
    Pillet, P
    Salomon, R
    Ulinski, T
    Bader-Meunier, B
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (02) : 390 - 390
  • [28] Clinicopathology of childhood-onset renal systemic lupus erythematosus
    Olowu, W.
    Adelusola, K.
    Senbanjo, I.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1619 - 1619
  • [29] An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus
    Vitor Cavalcanti Trindade
    Magda Carneiro-Sampaio
    Eloisa Bonfa
    Clovis Artur Silva
    Pediatric Drugs, 2021, 23 : 331 - 347
  • [30] PREDICTORS OF MORTALITY IN CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS
    Gacem, O.
    Zeroual, Z.
    Arrada, Z.
    Achir, Moussa
    Ladj, M. S.
    RHEUMATOLOGY, 2021, 60